115 related articles for article (PubMed ID: 31064016)
1. ZFP57-related Transient Neonatal Diabetes Responsive to Oral Sulfonylurea Treatment.
Reinauer C; Bergmann C; Jonasson A; Soditt V; Mayatepek E; Meißner T; Kummer S
Klin Padiatr; 2019 Jul; 231(4):225-226. PubMed ID: 31064016
[No Abstract] [Full Text] [Related]
2. Genome-wide DNA methylation analysis of transient neonatal diabetes type 1 patients with mutations in ZFP57.
Bak M; Boonen SE; Dahl C; Hahnemann JM; Mackay DJ; Tümer Z; Grønskov K; Temple IK; Guldberg P; Tommerup N
BMC Med Genet; 2016 Apr; 17():29. PubMed ID: 27075368
[TBL] [Abstract][Full Text] [Related]
3. Transient neonatal diabetes mellitus and hypomethylation at additional imprinted loci: novel ZFP57 mutation and review on the literature.
Touati A; Errea-Dorronsoro J; Nouri S; Halleb Y; Pereda A; Mahdhaoui N; Ghith A; Saad A; Perez de Nanclares G; H'mida Ben Brahim D
Acta Diabetol; 2019 Mar; 56(3):301-307. PubMed ID: 30315371
[TBL] [Abstract][Full Text] [Related]
4. A Newborn with Transient Diabetes Mellitus Accompanied by Ketoacidosis Attributable to a ZFP57 Mutation.
Iyigun F; Ozcan B; Kulali F; Celik IH; Cetinkaya S; Bas AY; Demirel N
J Trop Pediatr; 2017 Oct; 63(5):399-401. PubMed ID: 28334746
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57.
Mackay DJ; Callaway JL; Marks SM; White HE; Acerini CL; Boonen SE; Dayanikli P; Firth HV; Goodship JA; Haemers AP; Hahnemann JM; Kordonouri O; Masoud AF; Oestergaard E; Storr J; Ellard S; Hattersley AT; Robinson DO; Temple IK
Nat Genet; 2008 Aug; 40(8):949-51. PubMed ID: 18622393
[TBL] [Abstract][Full Text] [Related]
6. Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation.
Peña-Almazan S
Diabetes Res Clin Pract; 2015 Apr; 108(1):e18-20. PubMed ID: 25678012
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
[TBL] [Abstract][Full Text] [Related]
8. Transient neonatal diabetes mellitus in a Turkish patient with three novel homozygous variants in the ZFP57 gene.
Boyraz M; Ulucan K; Taşkın N; Akçay T; Flanagan SE; Mackay DJ
J Clin Res Pediatr Endocrinol; 2013; 5(2):125-8. PubMed ID: 23748067
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Molecular Characterization of Children with Neonatal Diabetes Mellitus at a Tertiary Care Center in Northern India.
Jain V; Satapathy A; Yadav J; Sharma R; Radha V; Mohan V; De Franco E; Ellard S
Indian Pediatr; 2017 Jun; 54(6):467-471. PubMed ID: 28667717
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of transient neonatal diabetes mellitus due to a novel homozygous c.7734C>T (p.R228C) mutation in
Kontbay T; Atar M; Demirbilek H
J Pediatr Endocrinol Metab; 2022 May; 35(5):695-698. PubMed ID: 35218690
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.
Tonini G; Bizzarri C; Bonfanti R; Vanelli M; Cerutti F; Faleschini E; Meschi F; Prisco F; Ciacco E; Cappa M; Torelli C; Cauvin V; Tumini S; Iafusco D; Barbetti F;
Diabetologia; 2006 Sep; 49(9):2210-3. PubMed ID: 16816952
[No Abstract] [Full Text] [Related]
12. Genetic and epigenetic mutations affect the DNA binding capability of human ZFP57 in transient neonatal diabetes type 1.
Baglivo I; Esposito S; De Cesare L; Sparago A; Anvar Z; Riso V; Cammisa M; Fattorusso R; Grimaldi G; Riccio A; Pedone PV
FEBS Lett; 2013 May; 587(10):1474-81. PubMed ID: 23499433
[TBL] [Abstract][Full Text] [Related]
13. Sulfonylurea-responsive neonatal diabetes mellitus diagnosed through molecular genetics in two children and in one adult after a long period of insulin treatment.
Fanciullo L; Iovane B; Gkliati D; Monti G; Sponzilli I; Cangelosi AM; Matrorilli C; Chiari G; Barbetti F; Dall'Aglio E; Vanelli M
Acta Biomed; 2012 Apr; 83(1):56-61. PubMed ID: 22978060
[TBL] [Abstract][Full Text] [Related]
14. Sulfonylurea-responsive diabetes in childhood.
Landau Z; Wainstein J; Hanukoglu A; Tuval M; Lavie J; Glaser B
J Pediatr; 2007 May; 150(5):553-5. PubMed ID: 17452235
[TBL] [Abstract][Full Text] [Related]
15. Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
Lemelman MB; Letourneau L; Greeley SAW
Clin Perinatol; 2018 Mar; 45(1):41-59. PubMed ID: 29406006
[TBL] [Abstract][Full Text] [Related]
16. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
Nagashima K; Inagaki N
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):737-41. PubMed ID: 19472523
[No Abstract] [Full Text] [Related]
17. [Values of osteocalcin in diabetes mellitus and their variations according to treatment].
Rico H; Cabranes JA; Hernández ER; Almoguera I
Med Clin (Barc); 1987 May; 88(20):798-800. PubMed ID: 3298878
[No Abstract] [Full Text] [Related]
18. Successful off-label sulfonylurea treatment of neonatal diabetes mellitus due to chromosome 6 abnormalities.
Garcin L; Kariyawasam D; Busiah K; Fauret-Amsellem AL; Le Bourgeois F; Vaivre-Douret L; Cavé H; Polak M; Beltrand J
Pediatr Diabetes; 2018 Jun; 19(4):663-669. PubMed ID: 29504184
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
Pou Torelló JM; Vilaclara JM
Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
[No Abstract] [Full Text] [Related]
20. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
